Medicare Enrolled

Dr. Corey Langer, MD

Internal Medicine · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
3400 CIVIC CENTER BLVD FL 3, Philadelphia, PA 19104
2156155858
In practice since 2006 (19 years)
NPI: 1811918501 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Langer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Langer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Langer

Dr. Corey Langer is an internal medicine specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Langer performed 660 Medicare services across 283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Langer received a total of $599,743 from 45 pharmaceutical and/or device companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Langer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 43% volume in PA $599,743 industry payments

Medicare Practice Summary

Medicare Utilization ↗
660
Medicare services
Top 43% in PA for internal medicine
283
Unique beneficiaries
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
612 $118 $267
New patient office visit, complex (60-74 min) 48 $150 $445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$599,743
Total received (2018-2024)
Avg $85,678/year across 7 years
Top 0% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$299,428 (49.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$233,772 (39.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66,543 (11.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,461
2023
$107,785
2022
$84,432
2021
$45,495
2020
$48,834
2019
$118,255
2018
$164,481

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$5,947
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,440
CATALYST PHARMACEUTICALS, INC.
$4,250
Novocure Inc.
$3,726
Janssen Biotech, Inc.
$3,683
AstraZeneca Pharmaceuticals LP
$2,365
PFIZER INC.
$1,800
Regeneron Pharmaceuticals, Inc.
$1,762
Regeneron Healthcare Solutions, Inc.
$1,689
Genentech USA, Inc.
$342
Fosun Pharma USA Inc.
$181
AstraZeneca UK Limited
$158
JAZZ PHARMACEUTICALS INC.
$118
Top 3 companies account for 48.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$153,892
AstraZeneca Pharmaceuticals LP
$76,060
Merck Sharp & Dohme LLC
$58,125
Takeda Pharmaceuticals U.S.A., Inc.
$48,353
Novocure Inc.
$27,565
GENZYME CORPORATION
$23,365
Lilly USA, LLC
$22,250
GlaxoSmithKline, LLC.
$21,220
Celgene Corporation
$20,412
Genentech USA, Inc.
$15,936
Gilead Sciences, Inc.
$10,358
Amgen Inc.
$10,142
PFIZER INC.
$10,104
Jazz Pharmaceuticals Inc.
$8,441
AstraZeneca UK Limited
$8,378
Catalyst Pharmaceuticals, Inc.
$7,832
Novartis Pharmaceuticals Corporation
$7,261
Genentech, Inc.
$6,412
Daiichi Sankyo Inc.
$6,280
Regeneron Healthcare Solutions, Inc.
$6,204
Dr.Reddy's Laboratories,Inc.
$5,000
Eli Lilly and Company
$4,725
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,440
CATALYST PHARMACEUTICALS, INC.
$4,250
Janssen Scientific Affairs, LLC
$4,053
Janssen Biotech, Inc.
$3,819
G1 Therapeutics, Inc.
$3,480
Eisai Inc.
$3,420
Regeneron Pharmaceuticals, Inc.
$3,164
JAZZ PHARMACEUTICALS INC.
$2,832
NOVARTIS PHARMACEUTICALS CORPORATION
$2,358
Bayer HealthCare Pharmaceuticals Inc.
$2,175
Blueprint Medicines Corporation
$2,156
Exelixis Inc.
$1,980
Varian Medical Systems, Inc.
$1,200
F. Hoffmann-La Roche AG
$939
EMD Serono, Inc.
$500
Fosun Pharma USA Inc.
$181
Bayer Healthcare Pharmaceuticals Inc.
$173
Mirati Therapeutics, Inc.
$155
Foundation Medicine, Inc.
$49
AbbVie, Inc.
$33
Bristol-Myers Squibb Company
$33
ImClone Systems, LLC
$25
Rigel Pharmaceuticals, Inc.
$17
Top 3 companies account for 48.0% of all-time payments
Associated products mentioned in payments ›
ALIMTA · ALUNBRIG · Alecensa · Avastin · BrachyVision · CABOMETYX · COSELA · CYRAMZA · Cabometyx · ENHERTU · Enhertu · FIRDAPSE · FOUNDATIONONE · IMFINZI · KEYTRUDA · KRAZATI · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · Non-Covered · Oncology · Optune · Optune Lua (NovoTTF-200T) · RYBREVANT · Rezlidhia · Serplulimab · TABRECTA · TAGRISSO · TECENTRIQ · Tecentriq · Tepmetko · Tislelizumab · Trodelvy · VELCADE · Vitrakvi · XALKORI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for internal medicine in PA.

Looking for an internal medicine specialist in Philadelphia?
Compare internal medicine physicians in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,328
Per 100K population
273.5
County median income
$60,698
Nearest hospital
PHILADELPHIA VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Langer is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 0% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Langer experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Langer performed 612 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Langer receive payments from pharmaceutical companies?
Yes. Dr. Langer received a total of $599,743 from 45 companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Langer's costs compare to other internal medicine physicians in Philadelphia?
Dr. Langer's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Langer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →